Does every classical type of well-differentiated thyroid cancer have excellent prognosis? A case series and literature review

References

• Manzella L, Stella S, Pennisi MS, et al. New insights in thyroid cancer and p53 family proteins. Int J Mol Sci. 2017;18:E1325. doi:10.3390/ijms1806132528635633
   PubMed Web of Science ®Google Scholar
• Pani F, Macerola E, Basolo F, Boi F, Scartozzi M, Mariotti S. Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: a case report. Oncol Lett. 2017;14:2186–2190. doi:10.3892/ol.2017.639528781658
   PubMed Web of Science ®Google Scholar
• Sobin LH. Histological typing of thyroid tumours. Histopathology. 1990;16:513. doi:10.1111/j.1365-2559.1990.tb01559.x
   PubMed Web of Science ®Google Scholar
• Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23:885–891. doi:10.1089/thy.2013.004523517343
   PubMed Web of Science ®Google Scholar
• Kaliszewski K, Strutyńska-Karpińska M, Zubkiewicz-Kucharska A, et al. Should the prevalence of incidental thyroid cancer determine the extent of surgery in multinodular goiter? PLoS One. 2016;11:e0168654. doi:10.1371/journal.pone.016865428005977
   PubMed Web of Science ®Google Scholar
• Kaliszewski K, Diakowska D, Wojtczak B, et al. Fine-needle aspiration biopsy as a preoperative procedure in patients with malignancy in solitary and multiple thyroid nodules. PLoS One. 2016;11:e0146883. doi:10.1371/journal.pone.014688326784518
   PubMed Web of Science ®Google Scholar
• Tuttle RM, Ball DW, Byrd D, et al. National comprehensive cancer network. J Natl Compr Canc Netw. 2010;8:1228–1274.21081783
   PubMed Web of Science ®Google Scholar
• Stratmann M, Sekulla C, Dralle H, Brauckhoff M. Current TNM system of the UICC/AJCC: the prognostic significance for differentiated thyroid carcinoma. Chirurg. 2012;83:646–651. doi:10.1007/s00104-011-2216-322273853
   PubMed Web of Science ®Google Scholar
• Gimm O, Dralle H. Differentiated thyroid carcinoma In: Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt; 2001 Available from: https://www.ncbi.nlm.nih.gov/books/NBK6979/
   Google Scholar
• Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest. 2012;35:3–9.23014067
   PubMed Web of Science ®Google Scholar
• Edge SE, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
   Google Scholar
• Paschke R, Lincke T, Müller SP, Kreissl MC, Dralle H, Fassnacht M. The treatment of well-differentiated thyroid carcinoma. Dtsch Arztebl Int. 2015;112:452–458. doi:10.3238/arztebl.2015.045226205749
   PubMed Web of Science ®Google Scholar
• Erler P, Keutgen XM, Crowley MJ, et al. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery. 2014;156:1342–1350. doi:10.1016/j.surg.2014.08.00725456905
   PubMed Web of Science ®Google Scholar
• Michels JJ, Jacques M, Henry-Amar M, Bardet S. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol. 2007;38:212–219. doi:10.1016/j.humpath.2006.08.00117097131
   PubMed Web of Science ®Google Scholar
• Gunalp B, Okuyucu K, Ince S, Ayan A, Alagoz E. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients. Hell J Nucl Med. 2017;20:122–127. doi:10.1967/s00244991055228697188
   PubMed Web of Science ®Google Scholar
• Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European thyroid cancer T: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787–803. doi:10.1530/eje.1.0215816728537
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. doi:10.1089/thy.2015.002026462967
   PubMed Web of Science ®Google Scholar
• Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:819–824. doi:10.1001/archotol.130.7.81915262757
   PubMedGoogle Scholar
• Clark OH. Thyroid cancer and lymph node metastases. J Surg Oncol. 2011;1003:615–618. doi:10.1002/jso.21804
   Web of Science ®Google Scholar
• Mazzaferri E, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418–428.7977430
   PubMed Web of Science ®Google Scholar
• Tubiana M, Schlumberger M, Rougier P, et al. Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985;55:794–804.3967174
   PubMed Web of Science ®Google Scholar
• Miftari R, Topciu V, Nura A, Haxhibeqiri V. Management of the patient with aggressive and resistant papillary thyroid carcinoma. Med Arch. 2016;70:314–317. doi:10.5455/medarh.2016.70.314-31727703298
   PubMedGoogle Scholar
• Pillai S, Gopalan V, Smith RA, Lam AKY. Diffuse sclerosing variant of papillary thyroid carcinoma – an update of its clinic pathological features and molecular biology. Crit Rev Oncol Hematol. 2015;94:64–73. doi:10.1016/j.critrevonc.2014.12.00125577570
   PubMed Web of Science ®Google Scholar
• Dralle H, Musholt TJ, Schabram J, et al. German association of endocrine surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg. 2013;398:347–375.23456424
   PubMed Web of Science ®Google Scholar
• Nath MC, Erickson LA. Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv Anat Pathol. 2018;25:172–179. doi:10.1097/PAP.000000000000018429351089
   PubMed Web of Science ®Google Scholar
• Kaliszewski K, Diakowska D, Strutyńska-Karpińska M, et al. Diagnostics of thyroid malignancy and indications for surgery in the elderly and younger counterparts: comparison of 3,749 patients. Biomed Res Int. 2017;2017:1012451. doi:10.1155/2017/101245129124061
   PubMed Web of Science ®Google Scholar
• Yunta PJ, Ponce JL, Prieto M, Merino F, Sancho-Fornos S. The importance of a tumor capsule in columnar cell thyroid carcinoma: a report of two cases and review of the literature. Thyroid. 1999;9:815–819. doi:10.1089/thy.1999.9.81510482375
   PubMed Web of Science ®Google Scholar
• Sacks W. Management of aggressive metastatic papillary thyroid cancer involves multiple treatment methods. Clin Thyroidology. 2013;25:20–23.
   Google Scholar
• Volante M, Collini P, Nikiforov Y, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31:1256–1264. doi:10.1097/PAS.0b013e3180309e6a17667551
   PubMed Web of Science ®Google Scholar
• Marti JL, Clark VE, Harper H, et al. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid. 2012;22:400–406. doi:10.1089/thy.2011.016222181336
   PubMed Web of Science ®Google Scholar
• Kuo EJ, Goffredo P, Sosa JA, Roman SA. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid. 2013;23:1305–1311. doi:10.1089/thy.2012.056323600998
   PubMed Web of Science ®Google Scholar